Joseph C.

Joseph C. possesses extensive experience in the pharmaceutical and healthcare sales sectors, currently serving in a role focused on rare diseases at Pfizer since June 2024. Prior positions include work as a Specialty Account Manager for Rare Disease at Amgen and Horizon Therapeutics, where Joseph C. successfully marketed the orphan drug Tepezza to various medical specialists. Prior to these roles, experience at Gilead Sciences and Eli Lilly & Company included institutional sales and the launch of innovative biologics like Emgality for migraine prevention. Joseph C. began the career in technical services and field operations with various companies, building a solid foundation with a Bachelor of Science in Business Administration from the University of Phoenix and multiple degrees in aeronautics and aviation technology.